ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

SEEL Seelos Therapeutics Inc

0.2855
0.0065 (2.33%)
Last Updated: 08:57:48
Delayed by 15 minutes

Period:

Draw Mode:

Volume 50,191
Bid Price 0.2855
Ask Price 0.29
News -
Day High 0.30

Low
0.2705

52 Week Range

High
49.80

Day Low 0.2855
Share Name Share Symbol Market Stock Type
Seelos Therapeutics Inc SEEL NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.0065 2.33% 0.2855 08:57:48
Open Price Low Price High Price Close Price Previous Close
0.2932 0.2855 0.30 0.279
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
163 50,191 US$ 0.293467 US$ 14,729 - 0.2705 - 49.80
Last Trade Type Quantity Price Currency
08:58:05 76 US$ 0.2855 USD

Seelos Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
4.1M 13.68M - 2.2M -37.88M -2.77 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Seelos Therapeutics News

Date Time Source News Article
3/06/202416:32Edgar (US Regulatory)Form S-1/A - General form for registration of securities..
3/06/202415:50Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/01/202416:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/14/202415:50Edgar (US Regulatory)Form D - Notice of Exempt Offering of Securities
2/06/202416:26Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial..
2/02/202405:04Edgar (US Regulatory)Form S-1 - General form for registration of securities under..
1/30/202415:01Edgar (US Regulatory)Form 8-K - Current report
1/30/202405:05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]
1/22/202407:05Edgar (US Regulatory)Form 8-K - Current report
1/17/202420:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
1/17/202420:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
1/10/202415:16Edgar (US Regulatory)Form 8-K - Current report
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No SEEL Message Board. Create One! See More Posts on SEEL Message Board See More Message Board Posts

Historical SEEL Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.3270.32730.27050.2885882482,633-0.0415-12.69%
1 Month0.550.59880.27050.3966142414,428-0.2645-48.09%
3 Months0.751.360.27050.6835214430,117-0.4645-61.93%
6 Months5.5895.6490.27052.911,276,289-5.30-94.89%
1 Year20.30149.800.27059.582,057,960-20.02-98.59%
3 Years182.40186.900.270543.021,990,748-182.11-99.84%
5 Years89.10198.000.270565.082,046,277-88.81-99.68%

Seelos Therapeutics Description

Seelos Therapeutics Inc is a clinical-stage biotechnology company. The company is focused on developing products that address significant unmet needs in the Central Nervous System (CNS) disorders and other rare disorders.

Your Recent History

Delayed Upgrade Clock